Literature DB >> 2998022

Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points.

V I Agol, S G Drozdov, V P Grachev, M S Kolesnikova, V G Kozlov, N M Ralph, L I Romanova, E A Tolskaya, A V Tyufanov, E G Viktorova.   

Abstract

Recombinants with a centrally located crossover point were selected from crosses between poliovirus type 1 strains and intertypic (type 3/type 1) recombinants. Two such recombinants were characterized in some detail. In one of them (v1/a1-6), the 5' half of the genome was derived from a virulent type 1 strain, while the 3' half came from an attenuated type 1 strain. The genome of the other recombinant (a1/v1-7) had the reverse organization, with the 5' and 3' halves being derived from the type 1 attenuated and virulent strains, respectively. As deduced from the RNase T1 oligonucleotide maps, the a1/v1-7 genome also had a relatively short centrally located insert of the poliovirus type 3 origin. Both recombinants exhibited ts phenotypes. The RNA phenotypes of the recombinants corresponded to that of the parent donating the 3' half of the genome, v1/a1-6 and a1/v1-7 expressing RNA- and RNA +/- characters, respectively. Despite being a ts RNA- virus, v1/a1-6 proved to be neurovirulent when injected intracerebrally into Cercopithecus aethiops monkeys, although it exhibited a somewhat diminished level of pathogenicity as compared to its virulent type 1 parent. Recombinant a1/v1-7 behaved as an attenuated strain. These data supported our previous conclusion drawn from the experiments with intertypic poliovirus recombinants that the attenuated phenotype of poliovirus depends largely on the structure of the 5' half of its genome, although mutations of the 3' half may alleviate the virulence of the virus to a degree.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998022     DOI: 10.1016/0042-6822(85)90386-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.

Authors:  C Christodoulou; F Colbere-Garapin; A Macadam; L F Taffs; S Marsden; P Minor; F Horaud
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Intratypic recombination of polioviruses: evidence for multiple crossing-over sites on the viral genome.

Authors:  H Agut; K M Kean; C Bellocq; O Fichot; M Girard
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Vaccination against poliomyelitis: present possibilities and future prospects.

Authors:  J L Melnick
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

4.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

Authors:  B Baxt; V Vakharia; D M Moore; A J Franke; D O Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers.

Authors:  S Makino; J O Fleming; J G Keck; S A Stohlman; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.

Authors:  M M Georgescu; M Tardy-Panit; S Guillot; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  Isolation and characterization of recombinants between attenuated and virulent aphthovirus strains.

Authors:  A T Giraudo; A Sagedahl; I E Bergmann; J L La Torre; E A Scodeller
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

8.  Behavior of intertypic recombinants between virulent and attenuated aphthovirus strains in tissue culture and cattle.

Authors:  A T Giraudo; I Gomes; P A de Mello; E Beck; J L La Torre; E A Scodeller; I E Bergmann
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.

Authors:  M Tardy-Panit; B Blondel; A Martin; F Tekaia; F Horaud; F Delpeyroux
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Cell-dependent role for the poliovirus 3' noncoding region in positive-strand RNA synthesis.

Authors:  David M Brown; Steven E Kauder; Christopher T Cornell; Gwendolyn M Jang; Vincent R Racaniello; Bert L Semler
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.